Diabetes One of Five Diseases and Disorders Causing Employer Healthcare Costs To Rise, Inequities Reported
According to a report by Health Action Council and UnitedHealth Group, five diseases and disorders are responsible for a growing [...]
Talented Additions to Syneos Health Communications Team Expected to Help Achieve Lofty Goals
Syneos Health Communications has added five experts to their team. These additions include Mark Sudwell as Head of Value, Access, [...]
CMS Reports Record Healthcare Cost of Staggering $3.8 Trillion Pre-COVID-19
A recent report released by CMS notes that healthcare spending rose nearly 5 percent in 2019, equivalent to $3.8 trillion. [...]
COVID-19 Vaccination RWD Uploaded to TriNetX
TriNetX has added data relating to COVID-19 vaccinations to its platform. RWD (real world data) is expected to accelerate research [...]
Cytel Whitepaper on Increasing Development Productivity in Clinical Trials by 20%
Despite efforts to improve outcomes from clinical trials, the likelihood of success remains low. In the past decade, only one-third [...]
ReimbursementCodes Offers Payers a Solution to Rising Drug Prices, Report Details 129% Increase in Price of 9 Prescription Drugs
A new report reveals that the Average Wholesale Price of nine prescription drugs rose by 129% between 2010 and 2016, [...]
Webinar on Value Communication in Pharma Features HealthEconomics.Com Founder and CEO Dr. Patti Peeples
A webinar on the importance of value communication in pharma provides important insight for medical communications professionals. Patti Peeples, RPh, [...]
PRMA Consulting Declared a Top 10 Outsourcing Consulting Company
Pioneering magazine Pharma Tech Outlook has picked PRMA Consulting as a top consulting company. PRMA Consulting provides unique solutions related [...]
RWE Solution Provider Corrona, LLC, Rebrands to become CorEvitas, Broadens Scope of Company
Corrona, LLC, has announced that it will change its company name to CorEvitas. It will also expand its offerings in [...]
[Book Release] Value-Based Drug Pricing Guide on Flawed $500 Billion Industry Available for Preorder
The Right Price by Peter Neumann, ScD, Joshua Cohen, PhD, and Daniel Ollendorf, PhD, is available for preorder. It will [...]
CMS Outlook Details Major Changes for Payers and Providers, Provides Suggestions to Accelerate Switch to Value-Based Models and Improve Equity
A report from the University of Pennsylvania’s Leonard Davis Institute of Health Economics discusses the coming changes aimed at reducing [...]
New CMS Innovation Appointment Could Affect Medicare Drug Pricing Policy
Elizabeth Fowler has been appointed director of the Center for Medicare and Medicaid Innovation (CMMI). Her previous roles will provide [...]
COVID-19 Data Dashboard Provides Clear Vaccine Information for People With Disabilities
Researchers, students, and patient advocates at Johns Hopkins have revealed a new data dashboard tool that provides information on COVID-19 [...]
New CMS Director Could Indicate Shift in Medicare Prescription Drug Pricing Policy
Arielle Woronoff is joining the new administration as director of the CMS Office of Legislation. She previously held worked in [...]
JAMA Article Proposes HTA As Solution for Out-of-Control Prescription Drug Prices; Speculation That Biden Will Look to ICER Model
In a recent article published in JAMA, the authors note that the US spends more per capita for prescription drugs [...]
ICER Unsatisfied With Fibrogen’s Roxadustat Evidence; FDA Calls Advisory Committee
ICER held a meeting on February 11th, during which its independent appraisal committee agreed that it was not possible to [...]
NIH Statement on Improving Equity; Francis Collins Announces UNITE Initiative to Address Structural Racism in Biomedical Science
Dr. John Denny, CEO of the NIH’s All of Us Research Program, released a statement on how the NIH is [...]
Sanofi Publishes 2021 Report on Principles in Prescription Drug Pricing, Notes $890 Million in Patient Assistance Programs
Unjustified price increases continue to be a point of contention in the pharma industry. Sanofi has published a report aimed [...]
Novartis and NHS England Agree on Price of Costly SMA Drug; Zolgensma Nearly £1.8 Million per Dose
SMA (spinal muscular atrophy) is characterized by muscle weakness, paralysis, and eventual loss of movement. It is associated with extremely [...]
MSL Society Offers Wednesday Webinar on Navigating KOL Engagements During COVID-19
The Medical Science Liaison Society (MSLS) will host a webinar this Wednesday from 12 PM – 1 PM CST on [...]
ICER Reveals Prescription Drug Cost Sharing Policies, Concludes Many Will Dislike Findings
A recent ICER whitepaper discusses a range of policies designed to limit drug prices. It focuses on three main topics [...]
GOP Avoids Drug Cost Questions During Becerra HHS Hearings
Xavier Becerra is Biden’s pick for HHS (Health and Human Services). Earlier this week, he took questions from Republican lawmakers, [...]
Aetion’s Take on RWE Expansion in Europe
Aetion’s Ashley Jaska, Vice President of Science, and Nicholas Deltour, Vice President of Real-World Solutions, offered their insight into how [...]
Storage a Major Challenge in Genomics Tools for Precision Medicine
Genomics tools are driving progress in precision medicine. These tools, such as next generation sequencing (NGS) technologies, allow for large [...]
Prescription Drugs Only One Piece of High Healthcare Costs–Look to Provider Cost
Dr. Anupam Jena, an associate professor of healthcare policy at Harvard Medical School and doctor at Massachusetts General Hospital, shares [...]